Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial
Crossref DOI link: https://doi.org/10.1186/s13045-014-0052-x
Published Online: 2014-08-01
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Subbiah, Vivek
Meric-Bernstam, Funda
Mills, Gordon B
Shaw, Kenna R Mills
Bailey, Ann Marie
Rao, Priya
Ward, John F
Pagliaro, Lance C
License valid from 2014-08-01
Article History
Received: 8 June 2014
Accepted: 7 July 2014
First Online: 1 August 2014